Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2004 053 777.2 |
96 | EP file number | EAKZ | 17 19 6501.5 |
97 | EP publication number | EPN | 3300721 |
54 | Designation/title | TI | PROPYLENGLYKOLHALTIGE PEPTIDFORMULIERUNGEN, DIE ZUR HERSTELLUNG UND ZUM EINSATZ IN EINSPRITZVORRICHTUNGEN OPTIMAL SIND |
51 | IPC main class | ICM (ICMV) | A61K 9/00 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 38/26 (2006.01), A61K 38/28 (2006.01), A61K 47/10 (2006.01), A61K 47/18 (2006.01), A61K 47/20 (2006.01), A61K 47/26 (2006.01) |
22 | DE application date | DAT | Nov 18, 2004 |
96 | EP application date | EAT | Nov 18, 2004 |
43 | Date of first publication | OT | Apr 4, 2018 |
| Date of publication of grant | PET | Mar 6, 2019 |
71/73 | Applicant/owner | INH | Novo Nordisk A/S, Bagsvaerd, DK |
72 | Inventor | IN | Bonde, Claude, 2880 Bagsværd, DK; ENGELUND, Dorthe Kot, 2880 Bagsværd, DK; Pedersen, Tina Bjeldskov, 2880 Bagsværd, DK |
| Address for service | | Novo Nordisk A/S, 2880 BAGSVAERD, DK |
33 31 32
| Foreign priority | PRC PRNA PRDA
| DK 200301719 Nov 20, 2003
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003300721A1 Searchable text:
EP000003300721A1 Original document:
EP000003300721B1 Searchable text:
EP000003300721B1 Original document:
EP000003300721B2 Searchable text:
EP000003300721B2 |
43 | Date of first publication | EVT | Apr 4, 2018 |
| Date of the first transfer into DPMAregister | EREGT | Apr 4, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 16, 2025 (Show all update days)(Hide all update days)- Jan 16, 2025
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 08.01.2025: changed
- Dec 12, 2024
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 08.01.2025: new
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 08.01.2025: new
- Nov 20, 2024
- Status: changed
- Procedures: Administrative procedure, IP right lapsed through expiry of term of protection, 18.11.2024: new
- Oct 26, 2023; Oct 27, 2022; Oct 27, 2021; Oct 29, 2020; Jan 2, 2020; Dec 19, 2019; Oct 26, 2019; Aug 22, 2019; Mar 28, 2019; Feb 19, 2019; Feb 14, 2019; Aug 9, 2018
- Historical data not available for this/these date(s)
- Apr 4, 2018
- Date of the first transfer into DPMAregister
|